Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in treating both early and late onset alopecia areata.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

The 755-nm alexandrite laser effectively and quickly treats trichostasis spinulosa with minimal pain and no side effects.

The serum reduced thigh fat and improved skin firmness.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

The treatment combination is effective and generally safe for lung cancer.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Latanoprost 0.005% solution safely increases hair density and regrowth in scalp alopecia areata.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

A new method improves betulin delivery and shows promise in cancer treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.